Dr Scott Smid

Dr Scott Smid is a pharmacologist specializing in drug discovery and development research both in industry and academia. He maintains a strong research interest in experimental therapeutics applied towards novel treatments for gastrointestinal and neurodegenerative diseases. This includes investigating the biological actions of phytocannabinoids, synthetic cannabinoids and endocannabinoids in areas as diverse as gut function, inflammation and neurodegeneration. Current interests include novel ligand development for binding and inhibiting pathological aggregating proteins such as beta-amyloid and alpha-synuclein, which are associated with Alzheimer's and Parkinson's disease.

Appointments

Date	Position	Institution name
2015	Visiting Fellow	University of Western Australia, Perth
2012	Deputy Head	University of Adelaide, Adelaide
2010 - 2014	Postgraduate Coordinator	University of Adelaide, Adelaide
2006	Senior Lecturer	University of Adelaide, Adelaide

Awards and Achievements

Date	Type	Title	Institution Name	Amount
2012		Faculty International Conference Award (FICA)

Education

Date	Institution name	Country	Title
1991 - 1994	University of Adelaide, Adelaide	Australia	Doctor of Philosophy
1990	University of Adelaide, Adelaide	Australia	Honours Degree of Bachelor of Science (Class 1 Honours)
1979 - 1989	University of Adelaide, Adelaide	Australia	Bachelor of Science

Journals

Date	Citation
2017	Das,S, Smid,S, 2017, Identification of dibenzyl imidazolidine and triazole acetamide derivatives through virtual screening targeting amyloid beta aggregation and neurotoxicity in PC12 cells, European Journal of Medicinal Chemistry, 130, 354-364 10.1016/j.ejmech.2017.02.057
2017	Campaniello,M, Mavrangelos,C, Eade,S, Harrington,A, Blackshaw,L, Brierley,S, Smid,S, Hughes,P, 2017, Acute colitis chronically alters immune infiltration mechanisms and sensory neuro-immune interactions., Brain, Behavior, and Immunity, 60, 319-332 10.1016/j.bbi.2016.11.015
2017	Marsh,D, Das,S, Ridell,J, Smid,S, 2017, Structure-activity relationships for flavone interactions with amyloid β reveal a novel anti-aggregatory and neuroprotective effect of 2′,3′,4′-trihydroxyflavone (2-D08), Bioorganic and Medicinal Chemistry, 25, 14, 3827-3834 10.1016/j.bmc.2017.05.041
2016	Safdari,B, Sia,T, Wattchow,D, Smid,S, 2016, Effects of pro-inflammatory cytokines, lipopolysaccharide and COX-2 mediators on human colonic neuromuscular function and epithelial permeability, Cytokine, 83, 231-238 10.1016/j.cyto.2016.04.017
2016	Gibson,R, Coller,J, Wardill,H, Hutchinson,M, Smid,S, Bowen,J, 2016, Chemotherapy-induced gut toxicity and pain: involvement of TLRs, Supportive Care in Cancer, 24, 5, 2251-2258 10.1007/s00520-015-3020-2
2016	Alghazwi,M, Kan,Y, Zhang,W, Gai,W, Garson,M, Smid,S, 2016, Neuroprotective activities of natural products from marine macroalgae during 1999–2015, Journal of Applied Phycology, 28, 6, 3599-3616 10.1007/s10811-016-0908-2
2016	Das,S, Stark,L, Musgrave,I, Pukala,T, Smid,S, 2016, Bioactive polyphenol interactions with β amyloid: a comparison of binding modelling, effects on fibril and aggregate formation and neuroprotective capacity, Food & Function, 7, 2, 1138-1146 10.1039/c5fo01281c
2014	Harvey,B, Sia,T, Wattchow,D, Smid,S, 2014, Interleukin 17A evoked mucosal damage is attenuated by cannabidiol and anandamide in a human colonic explant model, Cytokine, 65, 2, 236-244 10.1016/j.cyto.2013.10.006
2014	Janefjord,E, Maag,J, Harvey,B, Smid,S, 2014, Cannabinoid effects on β amyloid fibril and aggregate formation, neuronal and microglial-activated neurotoxicity in vitro, Cellular and Molecular Neurobiology, 34, 1, 31-42 10.1007/s10571-013-9984-x
2013	Nicotra,L, Vu,M, Harvey,B, Smid,S, 2013, Prostaglandin ethanolamides attenuate damage in a human explant colitis model, Prostaglandins & Other Lipid Mediators, 100, 1, 22-29 10.1016/j.prostaglandins.2013.01.003
2013	Wong,D, Musgrave,I, Harvey,B, Smid,S, 2013, Açaí (Euterpe oleraceae Mart.) berry extract exerts neuroprotective effects against β-amyloid exposure in vitro, Neuroscience Letters, 556, 221-226 10.1016/j.neulet.2013.10.027
2013	Harvey,B, Nicotra,L, Vu,M, Smid,S, 2013, Cannabinoid CB2 receptor activation attenuates cytokine-evoked mucosal damage in a human colonic explant model without changing epithelial permeability, Cytokine (Online), 63, 2, 209-217 10.1016/j.cyto.2013.04.032
2012	Smid,S, Maag,J, Musgrave,I, 2012, Dietary polyphenol-derived protection against neurotoxic β-amyloid protein: from molecular to clinical, Food & Function: linking the chemistry and physics of food with health and nutrition, 3, 12, 1242-1250 10.1039/c2fo30075c
2012	Harvey,B, Ohlsson,K, Maag,J, Musgrave,I, Smid,S, 2012, Contrasting protective effects of cannabinoids against oxidative stress and amyloid-β evoked neurotoxicity in vitro, Neurotoxicology, 33, 1, 138-146 10.1016/j.neuro.2011.12.015
2012	Harvey,B, Smid,S, 2012, The gastrointestinal endocannabinoid system in health and inflammation, Current Topics in Pharmacology, 16, 1, 107-118
2011	Harvey,B, Musgrave,I, Ohlsson,K, Fransson,A, Smid,S, 2011, The green tea polyphenol (−)-epigallocatechin-3-gallate inhibits amyloid-β evoked fibril formation and neuronal cell death in vitro, Food Chemistry, 129, 4, 1729-1736 10.1016/j.foodchem.2011.06.040
2009	Smid,S, Svensson,K, 2009, Inhibition of cyclooxygenase-2 and EP₁ receptor antagonism reduces human colonic longitudinal muscle contractility in vitro, Prostaglandins & Other Lipid Mediators, 88, 3-4, 117-121 10.1016/j.prostaglandins.2008.12.004
2009	Smid,S, 2009, Role of prostaglandins and specific place in therapy of bimatoprost in the treatment of elevated intraocular pressure and ocular hypertension: A closer look at the agonist properties of bimatoprost and the prostamides, Clinical Ophthalmology (online), 3, 1, 663-670 10.2147/opth.s6337
2008	Smid,S, 2008, Gastrointestinal endocannabinoid system: Multifaceted roles in the healthy and inflamed intestine, Clinical and Experimental Pharmacology and Physiology, 35, 11, 1383-1387 10.1111/j.1440-1681.2008.05016.x
2007	Smid,S, Bjorklund,C, Svensson,K, Heigis,S, Revesz,A, 2007, The endocannabinoids anandamide and 2-arachidonoylglycerol inhibit cholinergic contractility in the human colon, European Journal of Pharmacology, 575, 1-3, 168-176 10.1016/j.ejphar.2007.07.036
2006	Hinds,N, Ullrich,K, Smid,S, 2006, Cannabinoid 1 (CB1) receptors coupled to cholinergic motorneurones inhibit neurogenic circular muscle contractility in the human colon, British Journal of Pharmacology, 148, 2, 191-199 10.1038/sj.bjp.0706710
2005	Smith,A, Smid,S, 2005, Impaired capsaicin and neurokinin-evoked colonic motility in inflammatory bowel disease, Journal of Gastroenterology and Hepatology, 20, 5, 697-704 10.1111/j.1440-1746.2005.03759.x
2002	Lehmann,A, Blackshaw,L, Branden,L, Carlsson,A, Jensen,J, Nygren,E, Smid,S, 2002, Cannabinoid receptor agonism inhibits transient lower esophageal sphincter relaxations and reflux in dogs, Gastroenterology, 123, 4, 1129-1134 10.1053/gast.2002.36025
2001	Smid,S, Blackshaw,L, 2001, GABA(B) receptors inhibit vagal afferent mechanoreceptor responses to gastric distension., GASTROENTEROLOGY, 120, 5, A5-A6
2001	Smid,S, Young,R, Isaacs,N, Blackshaw,L, 2001, GABABR expressed on vagal afferent neurones inhibit gastric mechanosensitivity in ferret proximal stomach, American Journal of Physiology - Gastrointestinal and Liver Physiology, 281, 6, G1494-G1501
2000	Smid,S, Blackshaw,L, 2000, Vagal ganglionic and nonadrenergic noncholinergic neurotransmission to the ferret lower oesophageal sphincter, Autonomic Neuroscience-Basic & Clinical, 86, 1-2, 30-36 10.1016/S1566-0702(00)00210-1
2000	Smid,S, Blackshaw,L, 2000, Vagal neurotransmission to the ferret lower oesophageal sphincter: inhibition via GABAB receptors, British Journal of Pharmacology, 131, 3, 624-630 10.1038/sj.bjp.0703602
2000	Staunton,E, Smid,S, Dent,J, Blackshaw,L, 2000, Triggering of transient LES relaxations in ferrets: role of sympathetic pathways and effects of baclofen, American Journal of Physiology-Gastrointestinal and Liver Physiology, 279, 1 42-1, G157-G162
2000	Blackshaw,L, Page,A, Smid,S, Dent,J, Lehmann,A, 2000, GABAB receptors - peripheral and central targets for controlling gastroesophageal reflux, Current Opinion in Central & Peripheral Nervous System Investigational Drugs, 2, 3, 333-343
2000	Blackshaw,L, Smid,S, Dent,J, O'Donnell,T, 2000, GABAB receptor-mediated effects on vagal pathways to the lower oesophageal sphincter and heart, British Journal of Pharmacology, 130, 2, 279-288 10.1038/sj.bjp.0703244
2000	Smid,S, Blackshaw,L, 2000, Neuromuscular function of the human lower oesophageal sphincter in reflux disease and Barrett's oesophagus, Gut, 46, 6, 756-761 10.1136/gut.46.6.756
1995	Smid,S, Frewin,D, Wyartt,C, Head,R, 1995, Functional tolerance to a-adrenergic receptor blockade in the spontaneously hypertensive rat highlights the multi-functional role of vascular angiotensin II in the development of hypertension, Journal of Vascular Research, 32, 4, 247-253 10.1159/000159099

Book Chapters

Date	Citation
2014	Das,S, Smid,SD, 2014, The Antiaggregative, Antiamyloid Properties of Bioactive Polyphenols in the Treatment of Alzheimer's Disease, Academic Press, United Kingdom, pp. 73-76 10.1016/B978-0-12-411462-3.00008-4
2013	Smid,S, Musgrave,I, 2013, Dietary polyphenols as inhibitors of Β-amyloid-evoked neurotoxicity: implications for the treatment of Alzheimer's disease, Nova Science Publishers, United States, pp. 521-538
2009	Smid,S, 2009, Neuronal mechanosensitivity in the gastrointestinal tract, Springer, Russia, pp. 87-106 10.1007/978-1-4020-8716-5_5

Conference Items

Date	Citation
2015	Smid,S, Das,S, Musgrave,I, Pukala,T, 2015, Bioactive polyphenol interactions with beta amyloid: a comparison of binding, fibril inhibition and neuroprotection, 25th Biennial Meeting of the International-Society-for-Neurochemistry Jointly with the 13th Meeting of the Asian-Pacific-Society-for-Neurochemistry in Conjunction with the 35th Meeting of the Australasian-Neuroscience-Society, Cairns, AUSTRALIA
2011	Smid,S, Salem,A, Musgrave,I, 2011, Blended learning approaches to practical teaching in pharmacology: the best of both worlds?, ERGA Conference, Adelaide, Australia
2010	Salem,A, Smid,S, Musgrave,I, Carrington,A, 2010, Development and integration of web-based pharmacology e-resources designed to provide immediate feedback and interactive help, ERGA Conference, Adelaide, Australia

Grants and Funding

Development Initiatives and Funding: Teaching and Internationalisation

2015	Priority Partner Funding Grant, Nagoya University. Linkage facilitation.	$3000
2014-15	BEACON Set-Up Grants for New Study Tours. Establishing a program of study abroad electives for Bachelor of Health Sciences students to Sweden.	$5,000
2013	International Office, University of Gothenburg. G. Tobin, M Winder, P. Aronsson and S Smid. "International mobility: Extended bilateral cooperation with the University of Adelaide".	30,000 SEK
2011-12	Seminar: Blended learning approaches to practical teaching in pharmacology: the best of both worlds? 6th ERGA Conference, University of Adelaide, Sep. 28-30. Seminar: Development of discipline specific teaching tools based on LabTutor to improve practicum delivery. ASCEPT Education Workshop, Perth, Dec.4. 2011. Seminar: e-learning in an online environment in pharmacokinetics. e-learning forum, School of Medical Sciences, Sep. 3, 2012.

Research Support and Scholarship

2013-15	Co-Investigator (with Ian Musgrave, Louise O’Keefe and Tara Pukala). 'Structure function relationships of anti-amyloid drugs: verification in an in-vivo model.' lnterdisciplinary Research Fund Grant, The University of Adelaide.	AUD $21,000.
2011-13	Principal Investigator. (Associate Investigator: Dr Rachel Gibson). Validation of an ex vivo human colonic mucosal explant colitis model. MAWA Trust Research Grant.	AUD $28,122.
2013	Principal Investigator (with Drs A. Humpage and L. Fabbro). Characterisation of cyanobacterial Limnothrix muco- and neurotoxicity. School of Medical Sciences SRE project funding.	AUD $3000.
2010-12	Principal Investigator Broad Medical Research Program, (IBD-0268R). Functional Expression of the Endocannabinoid System in Inflammatory Bowel Disease.	USD $130,000

Teaching and Course Coordination

2006-present

The University of Adelaide: Course Coordinator - Pharmacology 3010/3011 (Level 3 B.Sc., B.Hlth.Sci). Pharmacology 2100/2200 (Level 2 B.Hlth.Sci, B. Pharm. Eng.). Pharmacology for Nursing (Level 1&2, Bachelor of Nursing). Higher Degree by Research: Discipline Coordinator (2007-2014).

Supervision

Research Supervision – postgraduate

2013-	Sukanya Das. Computational predictive analysis of β amyloid aggregation inhibitors as novel treatments for Alzheimer’s disease. PhD candidate. FHS Divisional Scholar.
2010-2014	Benjamin Harvey. Role of Endocannabinoid System and Prostamides in the Development of Colitis and Inflammatory Bowel Disease. PhD conferred July 31, 2014. Awarded Dean’s Commendation for Doctoral Thesis Excellence. APA Scholar.
2015-	Adjunct co-supervisor, Mr Mousa Alghazwi. PhD candidate, CMBD and Department of Medical Biotechnology, Flinders University. Characterization of neuroprotective compounds in from marine sponges and macroalgae in South Australia.
2016-	Co-supervisor, Ms Nicole Dmochowska, PhD candidate. Characterising the immune profile in Inflammatory Bowel Disease using novel in-vivo imaging technologies. APA and Southcott Memorial Scholarship holder in nuclear medicine.
2016-	Co-supervisor, Mr Chen Gao. PhD candidate. Development of a novel transgenic drosophila model for studying bioactive based neuroprotection against Alzheimer’s disease. FHS Divisional Scholar. 3
2017	Dylan Marsh (PhD). Enteric neurons as a model system to investigate protein amyloidosis and drug interventions
2017	Dylan Whan (PhD) Marine Bioproducts drug discovery related to inflammation and neuroprotection

Research – Other

2016	Contract research, CSIRO Materials, Parkville, Victoria. Bioavailability assays of small molecule herbal formulation extracts in Caco-2 monolayers
2010-11	Ms Megan Vu, Research Officer (contract employee on IBD-0268R)
2004-	Research thesis students, MSc (Pharm): Gothenburg (16), Uppsala (1). Vacation scholars (3)

Honours Supervision (Primary)

2016	Mr Dylan Whan, Mr Dylan Marsh (Norman Weir Scholarship for Parkinson’s Disease research), Ms Samantha Dama. Neuroprotection and medicinal chemistry projects.
2015	Ms Nicole Dmochowska (Class I), Mr Benjamin Hofma (Class I), Mr Samuel Eade (Class IIA). Various GI projects – colitis, cytokine/ motility and barrier function.
2013-14	Ms Bavani Gunasegaran (International). Cyclotherapy project. Class IIA
2012	Ms Baz Safdari (Class I). Cytokine effects on GI function. MAWA Honours Scholarship award, $10,000. Ms Daphne Wong (Class IIA.); β-amyloid and bioactive project.
2009	Ms Lauren Nicotra. Cannabinoids and colitis project (Class I). Mr Benjamin Harvey. (Class I). Natural products and neuroprotection project.
2004	Nick Hinds (CQU): Class I. Poster of merit AGW 2004 (Brisbane)
2001	Ms Alicia Smith (Class IIA). Dept of Physiology (affiliate), University of Adelaide

Memberships

Date	Role	Membership	Country
2017	Member	Australia New Zealand Marine Biotechnology Society	Australia
2016	Member	International Cannabinoid Research Society
2014	Member	International Society for Neurochemistry
2014		International Society for Neurochemistry
2006		International Cannabinoid Research Society
1991	Member	Australasian Society for Clinical and Experimental Pharmacology and Toxicology
1991		Australasian Society of Clinical and Experimental Pharmacology and Toxicology (ASCEPT).